Quadcap Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Buy
19,409
+581
+3% +$46.9K 0.15% 121
2026
Q1
$1.63M Sell
18,828
-87
-0.5% -$8.34K 0.19% 106
2025
Q4
$1.82M Sell
18,915
-343
-2% -$33.3K 0.21% 97
2025
Q3
$1.83M Sell
19,258
-652
-3% -$59.9K 0.22% 97
2025
Q2
$1.74M Sell
19,910
-125
-0.6% -$10.6K 0.22% 93
2025
Q1
$1.8M Buy
20,035
+1,160
+6% +$104K 0.26% 80
2024
Q4
$1.51M Sell
18,875
-1,480
-7% -$128K 0.22% 92
2024
Q3
$1.83M Sell
20,355
-2,200
-10% -$185K 0.29% 78
2024
Q2
$1.78M Buy
22,555
+3,271
+17% +$268K 0.32% 65
2024
Q1
$1.68M Sell
19,284
-2,595
-12% -$221K 0.38% 58
2023
Q4
$1.8M Buy
+21,879
New +$1.67M 0.47% 53

Other funds holding MDT

Quadcap Wealth Management's MDT Position: Q2 2026 in Review

Quadcap Wealth Management increased its Medtronic (MDT) stake by 3.1% in Q2 2026, buying an estimated $46.9K and bringing the position to 19,409 shares worth $1.52M. The position accounts for 0.15% of the portfolio, ranked #121.

Quadcap Wealth Management first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.83M in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Quadcap Wealth Management held 19,409 shares of Medtronic worth $1.52M as of Q2 2026.
  • Quadcap Wealth Management bought 581 Medtronic shares in Q2 2026, an estimated $46.9K.
  • Medtronic made up 0.15% of Quadcap Wealth Management's portfolio in Q2 2026, its #121 holding.
  • Quadcap Wealth Management first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Quadcap Wealth Management's Medtronic position peaked at $1.83M in Q3 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.